4-phenylbutyric acid has been researched along with arginine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Erez, A; Lee, B; Nagamani, SC | 1 |
| Albuquerque, JA; Castiblanco-Valencia, MM; Dos Santos, M; Isaac, L; Lamers, ML | 1 |
| Enokida, T; Ishiguro, T; Maruyama, T; Okamoto, Y; Otagiri, M; Seo, H; Taguchi, K; Yamasaki, K | 1 |
| Finnegan, J; Giva, S; Ihidero, P; Knerr, I; Maguire, G; Monavari, A; Power, B | 1 |
| Boussery, K; De Spiegeleer, B; Peeters, E; Remon, JP; Van Tongelen, I; Vanhoorne, V; Vervaet, C; Wynendaele, E | 1 |
| Fukui, K; Hanai, T; Ishibashi, H; Matsufuji, M; Nakashima, M; Takashima, S; Takeshita, E; Watanabe, Y | 1 |
| Ando, Y; Arisaka, O; Imataka, G; Ishii, J; Nitta, A; Takagi, Y; Yoshihara, S | 1 |
2 review(s) available for 4-phenylbutyric acid and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Argininosuccinate lyase deficiency.
Topics: Arginine; Argininosuccinate Lyase; Argininosuccinic Acid; Argininosuccinic Aciduria; Child, Preschool; Citrulline; Cognition Disorders; Diet, Protein-Restricted; Fumarates; Genetic Testing; Glucose; Humans; Hyperammonemia; Hypertension; Infant; Infant, Newborn; Lipids; Liver Diseases; Liver Transplantation; Neonatal Screening; Phenylbutyrates; Sodium Benzoate | 2012 |
6 other study(ies) available for 4-phenylbutyric acid and arginine
| Article | Year |
|---|---|
Chemical chaperones curcumin and 4-phenylbutyric acid improve secretion of mutant factor H R127H by fibroblasts from a factor H-deficient patient.
Topics: Amino Acid Substitution; Animals; Arginine; Cells, Cultured; Child; Chlorocebus aethiops; Complement Factor H; COS Cells; Curcumin; Fibroblasts; Histidine; Humans; Molecular Chaperones; Phenylbutyrates | 2012 |
Tyrosine411 and Arginine410 of Human Serum Albumin Play an Important Role in the Binding of Sodium 4-Phenylbutyrate to Site II.
Topics: Antineoplastic Agents; Arginine; Binding Sites; Humans; Phenylbutyrates; Protein Binding; Serum Albumin, Human; Tyrosine | 2016 |
Hyperammonaemia in Neonates and Young Children: Potential Metabolic Causes, Diagnostic Approaches and Clinical Consequences
Topics: Ammonia; Arginine; Biomarkers; Brain Diseases, Metabolic, Inborn; Carnitine; Critical Illness; Diet, Protein-Restricted; Early Diagnosis; Emergencies; Female; Humans; Hyperammonemia; Infant; Infant, Newborn; Male; Phenylbutyrates; Sodium Benzoate; Treatment Outcome | 2019 |
Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.
Topics: Arginine; Belgium; Carnitine; Drug Compounding; Excipients; Humans; Pharmacists; Phenylbutyrates; Primaquine; Pyridoxal Phosphate; Rare Diseases; Sodium Benzoate | 2019 |
Sodium phenylbutyrate improved the clinical state in an adult patient with arginase 1 deficiency.
Topics: Adult; Arginase; Arginine; Female; Humans; Hyperammonemia; Hyperargininemia; Phenylbutyrates | 2020 |
Long-term survival of a patient with acute neonatal-onset metabolic encephalopathy with carbamoyl phosphate synthetase 1 deficiency.
Topics: Arginine; Brain Diseases, Metabolic; Carbamoyl-Phosphate Synthase I Deficiency Disease; Carnitine; Female; Humans; Hyperammonemia; Infant, Newborn; Phenylbutyrates; Renal Dialysis; Sodium Benzoate | 2020 |